rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michele Greco

Chief Admin Officer and CFO

Company insider

Files Form 4 as: Chief Admin Officer and CFO, Veru.

In numbers

Trades disclosed
29
Buys
4
Sells
0
Bought
$62K
Sold
$0
Companies
1
Companies where not an officer
0
First trade
8 Mar 2013
Last trade
4 May 2026
Last filed
6 May 2026

Companies traded

Where they are an officer
VERU VeruOfficer · Biotechnology · last 4 May 20264 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 May 2026filed 6 May 2026VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—164,000 at $0.00filing
4 May 2026filed 6 May 2026VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—164,000 at $0.00filing
5 Dec 2025filed 9 Dec 2025VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—27,000 at $0.00filing
6 May 2025filed 8 May 2025VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—108,000 at $0.00filing
7 May 2024filed 9 May 2024VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—106,000 at $0.00filing
9 May 2023filed 11 May 2023VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—104,000 at $0.00filing
2 Nov 2022filed 4 Nov 2022VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—102,000 at $0.00filing
22 Apr 2022filed 25 Apr 2022VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
3 Nov 2021filed 5 Nov 2021VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—128,400 at $0.00filing
13 Nov 2020filed 17 Nov 2020VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—116,359 at $0.00filing
13 Nov 2020filed 17 Nov 2020VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—109,500 at $0.00filing
24 Aug 2020filed 26 Aug 2020VERU VeruBiotechnologySEC FORM 4 Bought$13K5,000 at $2.65filing
14 Nov 2019filed 18 Nov 2019VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—94,800 at $0.00filing
14 Nov 2019filed 18 Nov 2019VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—114,903 at $0.00filing
20 Aug 2019filed 22 Aug 2019VERU VeruBiotechnologySEC FORM 4 Bought$37K20,000 at $1.84filing
13 May 2019filed 21 May 2019VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—92,100 at $0.00filing
11 Dec 2018filed 13 Dec 2018VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—83,025 at $0.00filing
2 May 2018filed 4 May 2018VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code A—90,000 at $0.00filing
31 Oct 2016filed 2 Nov 2016VERU VeruBiotechnologySEC FORM 4 Code M—3,333filing
31 Oct 2016filed 2 Nov 2016VERU Veruoption or derivative · BiotechnologySEC FORM 4 Code M—3,333filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

K. Gary BarnetteChief Scientific Officer · Chief Scientific Officer at Veru, filing Form 4 there in the last year
Michael L. RankowitzDirector · Director at Veru, filing Form 4 there in the last year
Mitchell Shuster SteinerPresident and CEO · President and CEO at Veru, filing Form 4 there in the last year
Harry FischChief Corporate Officer · Chief Corporate Officer at Veru, filing Form 4 there in the last year
Grace HyunDirector · Director at Veru, filing Form 4 there in the last year